Vise Technologies’s Amicus Therapeutics FOLD Stock Holding History

Vise Technologies’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-69,715	Closed	-$993K	–	1887
2026 Q1	$993K	Hold	69,715	–	–	0.02%	588
2025 Q4	$993K	Buy	69,715 +6,493	+10%	+$63.8K	0.02%	592
2025 Q3	$498K	Buy	63,222 +30,533	+93%	+$217K	0.02%	669
2025 Q2	$187K	Buy	+32,689	New	+$211K	0.01%	1000

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Vise Technologies's FOLD Position: Q2 2026 in Review

Vise Technologies sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 69,715 shares — an estimated $993K sold.

Vise Technologies first reported a position in FOLD in Q2 2025 and held it in 4 quarters. The position peaked at $993K in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Vise Technologies reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Vise Technologies sold 69,715 Amicus Therapeutics shares in Q2 2026, an estimated $993K.
Vise Technologies first reported a position in Amicus Therapeutics in Q2 2025 and held it in 4 quarters.
Vise Technologies's Amicus Therapeutics position peaked at $993K in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.